Frequently Asked Questions Q 1: Who qualifies for GLP-1 weight loss prescriptions in Ireland A 1: You need a BMI of 30+ or BMI 27-30 with weight-related conditions like diabetes or high blood pressure
Typically, candidates include: Adults 25+ with a BMI over 25 Individuals with weight-related health conditions Those who have struggled with traditional diet and exercise approaches People committed to lifestyle changes alongside medication Those without contraindications to GLP-1/GIP agonist therapy Our physicians will evaluate your complete medical history to determine if tirzepatide is safe and appropriate for your situation
Prevention strategies can significantly reduce injection site reactions: Proper temperature: Follow your product's PIL
Advances in oral delivery of peptide-based medications have resulted in the development of an oral formulation of semaglutide (Rybelsus) which was recently approved by the FDA for the treatment of T2DM
If you experience vomiting or diarrhea lasting more than 24 hours, standard guidance for oral contraceptives recommends continuing backup contraception until you have taken your pill for seven consecutive days after symptoms resolve
Functionally, semaglutide retains full agonist potency at the human GLP-1 receptor